Prostatype Genomics presents Quarterly Report
Prostatype Genomics AB has today published its quarterly report for the third quarter comprising the period from 1 July 2022 to 30 September 2022. The report is available on the company website .Quarter 3 (1 January – 30 June 2022 compared with 1 July – 30 September 2022) summarized · Net sales amounted to 109 (0) TSEK. · Net revenue amounted to 110 (426) TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -7 175 (-3 613) TSEK. · Cash flow from current operations in the quarter amounted -8 526 (-3 831)